Acceleron Pharma Inc. XLRN NASDAQ

NASDAQ Global Market • Healthcare • Biotechnology • US • USD

SharesGrow Score

39/100

1/7 Pass

SharesGrow Intrinsic Value

There have been 50 recent insider transactions recorded for Acceleron Pharma Inc. (XLRN), including 16 buys and 32 sells. Total insider buying was valued at $13.79M and total insider selling at $14.86M.

Notable insiders with recent activity include Mclaughlin Kevin F, Kearney Terrence C, Zakrzewski Joseph S. Insider transactions can provide insights into how company leadership views the stock's valuation and future prospects.

Insider Transactions — XLRN

Date	Name	Role	Transaction	Shares	Avg. Price	Value	Shares Owned
2021-11-19	Mclaughlin Kevin F	SVP, CFO and Treasurer	Return of Shares	18,806	$115.53	$2.17M	-
2021-11-19	Kearney Terrence C	Director	Return of Shares	3,222	$115.53	$372.24K	-
2021-11-19	Zakrzewski Joseph S	Director	Return of Shares	3,222	$115.53	$372.24K	-
2021-11-19	Kango Sujay	EVP, Chief Commercial Officer	Return of Shares	20,896	$115.53	$2.41M	-
2021-11-19	Nader Francois	Director	Return of Shares	3,222	$115.53	$372.24K	-
2021-11-19	Mccourt Thomas A	Director	Return of Shares	3,222	$115.53	$372.24K	-
2021-11-19	Hamill Laura	Director	Return of Shares	941	$115.53	$108.71K	-
2021-11-19	Backstrom Jay T.	EVP, Research and Development	Return of Shares	20,896	$115.53	$2.41M	-
2021-11-19	Hite Christopher	Director	Return of Shares	1,848	$115.53	$213.5K	-
2021-09-27	Kango Sujay	EVP, Chief Commercial Officer	Informative Sell	5,000	$175.00	$875K	18,509
2021-09-24	Mclaughlin Kevin F	SVP, CFO and Treasurer	Informative Sell	5,370	$160.38	$861.24K	10,681
2021-09-23	Mclaughlin Kevin F	SVP, CFO and Treasurer	Option Exercise (Sell)	2,500	$30.17	$75.43K	2,663
2021-09-21	Kango Sujay	EVP, Chief Commercial Officer	Informative Sell	5,000	$150.03	$750.15K	18,509
2021-04-19	Mccourt Thomas A	Director	Option Exercise (Sell)	7,500	$40.61	$304.58K	-
2021-04-05	Zakrzewski Joseph S	Director	Option Exercise (Sell)	10,000	$24.11	$241.1K	-
2021-04-01	Zakrzewski Joseph S	Director	Option Exercise (Sell)	10,000	$24.11	$241.1K	10,000
2021-03-02	Kango Sujay	EVP, Chief Commercial Officer	Informative Sell	200	$138.15	$27.63K	19,396
2021-02-12	Kango Sujay	EVP, Chief Commercial Officer	Tax Withholding of RSU	887	$130.87	$116.08K	18,509
2021-01-29	Mclaughlin Kevin F	SVP, CFO and Treasurer	RSU Award	4,868	-	-	10,681
2021-01-29	Kearney Terrence C	Director	RSU Award	3,222	$115.53	$372.24K	3,222
2021-01-29	Zakrzewski Joseph S	Director	RSU Award	3,222	$115.53	$372.24K	3,222
2021-01-29	Kango Sujay	EVP, Chief Commercial Officer	RSU Award	5,409	-	-	19,396
2021-01-29	Nader Francois	Director	RSU Award	3,222	$115.53	$372.24K	3,222
2021-01-29	Mccourt Thomas A	Director	RSU Award	3,222	$115.53	$372.24K	3,222
2021-01-29	Hamill Laura	Director	RSU Award	474	-	-	474
2021-01-29	Backstrom Jay T.	EVP, Research and Development	RSU Award	5,409	-	-	20,781
2021-01-29	Hite Christopher	Director	RSU Award	930	-	-	930
2021-01-05	Mclaughlin Kevin F	SVP, CFO and Treasurer	Informative Sell	4	$123.50	$494.00	5,813
2021-01-04	Mclaughlin Kevin F	SVP, CFO and Treasurer	Informative Sell	300	$124.45	$37.34K	7,312
2021-01-04	Kango Sujay	EVP, Chief Commercial Officer	Informative Sell	4,624	$126.15	$583.32K	3,987
2021-01-04	Backstrom Jay T.	EVP, Research and Development	Tax Withholding of RSU	1,735	$124.31	$215.68K	15,372
2021-01-04	Kango Sujay	EVP, Chief Commercial Officer	Option Exercise	10,000	$40.61	$406.1K	13,987
2020-12-14	Mclaughlin Kevin F	SVP, CFO and Treasurer	Option Exercise (Sell)	7,700	$27.97	$215.37K	-
2020-12-11	Mclaughlin Kevin F	SVP, CFO and Treasurer	Option Exercise (Sell)	3,100	$41.20	$127.72K	7,252
2020-12-10	Mclaughlin Kevin F	SVP, CFO and Treasurer	Option Exercise (Sell)	200	$27.97	$5.59K	7,700
2020-12-09	Mclaughlin Kevin F	SVP, CFO and Treasurer	Option Exercise (Sell)	400	$27.97	$11.19K	7,900
2020-10-12	Kearney Terrence C	Director	Option Exercise (Sell)	7,500	$30.17	$226.28K	-
2020-09-15	Hamill Laura	Director	Unknown	-	-	-	-
2020-09-15	Hamill Laura	Director	RSU Award	9,339	$101.88	$951.46K	9,339
2020-09-11	Mccourt Thomas A	Director	Option Exercise (Sell)	3,272	$30.17	$98.72K	-
2020-07-09	Celgene Corp /de/	10 Percent Owner	Option Exercise (ITM)	38,979	$5.88	$229.2K	-
2020-07-01	Celgene Corp /de/	10 Percent Owner	Informative Buy	108,108	$92.50	$10M	6,971,772
2020-06-04	Hite Christopher	Director	Unknown	-	-	-	-
2020-06-04	Hite Christopher	Director	RSU Award	10,267	$92.09	$945.49K	10,267
2020-04-09	Mclaughlin Kevin F	SVP, CFO and Treasurer	Option Exercise (Sell)	17,226	$41.20	$709.71K	11,000
2020-04-08	Mclaughlin Kevin F	SVP, CFO and Treasurer	Option Exercise (Sell)	4,000	$24.11	$96.44K	-
2020-02-13	Kango Sujay	EVP, Chief Commercial Officer	Informative Sell	5	$94.82	$474.10	15,344
2020-01-22	Mclaughlin Kevin F	SVP, CFO and Treasurer	RSU Award	6,369	-	-	11,216
2020-01-22	Kearney Terrence C	Director	RSU Award	1,377	-	-	5,127
2020-01-22	George Jean	Director	RSU Award	1,377	-	-	5,127

■ Informative Buy/Sell — open market transaction (most significant) ■ Uninformative Buy — award, option exercise, conversion ■ Uninformative Sell — tax withholding, award vest sale ■ Neutral — gift, trust, expiry